Sean Maduck, See Remarks at CORCEPT THERAPEUTICS INC (CORT), sold 201,180 shares at $100.26 ($20.2M) on 2025-03-31, disclosed to the SEC on 2025-04-02.
Scheduled sale ($20.2M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.26 | 79,277 | $7.9M | 39.3% |
| 2 | $100.26 | 79,277 | $7.9M | 39.3% |
| 3 | $101.43 | 15,133 | $1.5M | 7.6% |
| 4 | $101.43 | 15,133 | $1.5M | 7.6% |
| 5 | $102.16 | 5,590 | $571K | 2.8% |
| 6 | $102.16 | 5,590 |
| $571K |
| 2.8% |
| 7 | $114.55 | 590 | $68K | 0.3% |
| 8 | $114.55 | 590 | $68K | 0.3% |
| Total | $100.63 avg | 201,180 | $20.2M | 100% |
| Filing → |
| CORT | SELL | 2026-08-18 | $419K | — | Filing → |
| CORT | SELL | 2026-08-12 | $118K | — | Filing → |
| CORT | SELL | 2026-08-05 | $2.3M | — | Filing → |